Emphysema reversed in the lungs of mice

Publicly released:
International
Image by Ralf Kunze from Pixabay
Image by Ralf Kunze from Pixabay

It is possible to reverse emphysema in mice, according to international researchers, who say they have also identified a gene that may be a driver of emphysema. Emphysema is a lung disease associated with long-term cigarette smoking, and the team was able to inject mice who suffered this condition with endothelial cells (cells that normally come from blood cells) and found that this regenerated and repaired the damaged tissues in the lungs of the mice. The team were also able to identify that a rise in the amount of a protein known as Leucine-rich α-2-glycoprotein-1 (LRG1) in the lungs appeared to be contributing to the development of emphysema, and by suppressing the gene that produces LRG1, they helped protect the mice against emphysema.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Rockefeller University Press, Web page URL will go live after the embargo lifts
Journal/
conference:
Journal of Experimental Medicine
Research:Paper
Organisation/s: Weill Cornell Medicine, USA
Funder: This work was supported by National Institutes of Health grants R01HL132198, P01Hl114501 (to A.M.K. Choi), R00 HL125899 (to S.M. Cloonan), 5T32HL134629 (to A.C. Racanelli), R35 HL150809, U01 AI 138329, RC2 DK11477 (to S. Rafii), CRIM (to M. Ginsberg and D.J. Nolan), T32 HD060600, and RFA#0906290930 (to B. Kunar), Leukemia and Lymphoma Society (to J.M. Scandura), the Cancer Research and Treatment Fund (to J.M. Scandura, P. Kermani), the Taub Foundation (to J.M. Scandura, P. Kermani), the National Heart, Lung, and Blood Institute (to J.M. Scandura, P. Kermani), the Daedalus Fund for Innovation from Weill Cornell Medicine, and the Tri-Institutional Stem Cell Initiatives (TRI-SCI 2019-029 to S. Rafii).
Media Contact/s
Contact details are only visible to registered journalists.